Clinical presentation of exclusive cystic fibrosis lung disease

被引:11
作者
Bronsveld, I [1 ]
Bijman, J
Mekus, F
Ballmann, M
Veeze, HJ
Tümmler, B
机构
[1] Erasmus Univ, Dept Paediat, Rotterdam, Netherlands
[2] Erasmus Univ, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands
[3] Sophia Childrens Hosp, Dept Neonatol, Rotterdam, Netherlands
[4] Med Hsch Hannover, Dept Paediat, D-30623 Hannover, Germany
[5] Med Hsch Hannover, Clin CF Res Grp, D-30623 Hannover, Germany
关键词
cystic fibrosis; atypical cystic fibrosis; nasal potential difference; genetics;
D O I
10.1136/thx.54.3.278
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The diagnosis of cystic fibrosis (CF) is based on the occurrence of two mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and on assays that measure the basic defect of abnormal chloride transport in the affected organs. However, in cases of atypical CF not all diagnostic tests may be positive. We present a patient with an atypical CF phenotype in whom the only presenting symptom was severe CF-like lung disease substantiated by an abnormal nasal potential difference. Genetic analysis showed that the patient was a symptomatic heterozygote, which suggests that one lesion in the CFTR gene may be sufficient to cause CF-like lung disease.
引用
收藏
页码:278 / 281
页数:4
相关论文
共 24 条
  • [1] BAUTSCH W, 1997, GENOME MAPPING PRACT, P281
  • [2] PURIFICATION AND FUNCTIONAL RECONSTITUTION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)
    BEAR, CE
    LI, CH
    KARTNER, N
    BRIDGES, RJ
    JENSEN, TJ
    RAMJEESINGH, M
    RIORDAN, JR
    [J]. CELL, 1992, 68 (04) : 809 - 818
  • [3] Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes - The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation
    Cuppens, H
    Lin, W
    Jaspers, M
    Costes, B
    Teng, H
    Vankeerberghen, A
    Jorissen, M
    Droogmans, G
    Reynaert, I
    Goossens, M
    Nilius, B
    Cassiman, JJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) : 487 - 496
  • [4] DORK T, 1994, HUM GENET, V94, P533
  • [5] INTRAGENIC AND EXTRAGENIC MARKER HAPLOTYPES OF CFTR MUTATIONS IN CYSTIC-FIBROSIS FAMILIES
    DORK, T
    NEUMANN, T
    WULBRAND, U
    WULF, B
    KALIN, N
    MAASS, G
    KRAWCZAK, M
    GUILLERMIT, H
    FEREC, C
    HORN, G
    KLINGER, K
    KEREM, BS
    ZIELENSKI, J
    TSUI, LC
    TUMMLER, B
    [J]. HUMAN GENETICS, 1992, 88 (04) : 417 - 425
  • [6] Cystic fibrosis 3849+10kb C>T mutation associated with severe pulmonary disease and male fertility
    Dreyfus, DH
    Bethel, R
    Gelfand, EW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) : 858 - 860
  • [7] A CYSTIC-FIBROSIS MUTATION ASSOCIATED WITH MILD LUNG-DISEASE
    GAN, KH
    VEEZE, HJ
    VANDENOUWELAND, AMW
    HALLEY, DJJ
    SCHEFFER, H
    VANDERHOUT, A
    OVERBEEK, SE
    DEJONGSTE, JC
    BAKKER, W
    HEIJERMAN, HGM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (02) : 95 - 99
  • [8] GIBSON LE, 1959, PEDIATRICS, V23, P545
  • [9] CLINICAL SPECTRUM IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES INHERITING CYSTIC-FIBROSIS MUTATION 3849+10KBC-GREATER-THAN-T - SIGNIFICANCE FOR GENETICISTS
    GILBERT, F
    LI, Z
    ARZIMANOGLOU, I
    BIALER, M
    DENNING, C
    GORVOY, J
    HONOROF, J
    ORES, C
    QUITTELL, L
    ROSSOFF, L
    VALVERDE, K
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 58 (04): : 356 - 359
  • [10] A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS
    HIGHSMITH, WE
    BURCH, LH
    ZHOU, ZQ
    OLSEN, JC
    BOAT, TE
    SPOCK, A
    GORVOY, JD
    QUITTELL, L
    FRIEDMAN, KJ
    SILVERMAN, LM
    BOUCHER, RC
    KNOWLES, MR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (15) : 974 - 980